Battery Life Can Help Save a Life – Energizer® supports Diabetes Australia 21 May 2019 Energizer Australia Pty. Ltd. (“Energizer”) will support National Diabetes Week for the fourth year in a row and will donate $1 from the purchase of every specially marked pack of Energizer® batteries to Diabetes Australia to support the organisation’s life-changing work. The money raised will help Diabetes Australia assist people living with diabetes and fund critical diabetes research through the Diabetes Australia Research Program. The Program funds diabetes research into all facets of diabetes including, hopefully, a cure. Energizer has a 120 year history of innovation in batteries and is currently the maker of the world’s longest lasting AA battery (Energizer® Ultimate Lithium™). Diabetes Australia CEO Professor Greg Johnson welcomed Energizer’s support of National Diabetes Week for a fourth consecutive year. “It is wonderful that Energizer is once again supporting Diabetes Australia in our efforts to raise awareness of diabetes and the need for more funding to support diabetes research,” Professor Greg Johnson said “Diabetes Australia is a charity and relies on long term support like this which is vital to sustaining our efforts.” “A cure for diabetes remains the ultimate goal – and our national research program brings us closer each day to a breakthrough.” Energizer business director David Pattison said the company was committed to supporting people with diabetes. “We are proud to stand with Diabetes Australia on their journey for a better future for people living with diabetes,” Mr Pattinson said. This National Diabetes Week, support life-saving research by buying a long lasting battery and improving the lives of people living with diabetes. Your purchase will support Diabetes Australia supporting Australia’s diabetes community. Keep an eye out for the Energizer® battery packs with $1 donation stickers in stores near you.
News 19 January 2026 National Diabetes Summit to convene at Federal Parliament Australia’s response to one of its most significant health challenges will come into sharp focus at Diabetes Australia’s National Diabetes... Continue Reading
News 16 January 2026 Wegovy to be listed on PBS The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended Wegovy (semaglutide) be subsidised through the Pharmaceutical Benefits Scheme (PBS) for adults with established cardiovascular disease and obesity. Diabetes Australia’s Group CEO... Continue Reading
Blog 15 January 2026 Five signs it’s time to book a diabetes telehealth appointment Accessing telehealth can be useful if you are newly diagnosed, you feel unwell, or if you are navigating a life transition. Continue Reading